/Investor DB

Canaan Partners — 2016 Investments

11 investments dated 2016 · listed companies and verified rows first · show all

DexComdexcom.cominNASDAQ: DXCMMay 2016

Dexcom develops continuous glucose monitoring (CGM) systems and glucose biosensors, including the Dexcom G7 and the over-the-counter Stelo biosensor, that send real-time glucose readings to a phone or receiver.

BiotechDigital HealthHealthtechMedical DevicesSan Diego, US

Richard Doubleday(Executive Officer)Steven R. Pacelli(Executive Officer)inJeffrey Moy(Executive Officer)Terrance H. Gregg(Executive Officer, Director)Jorge Valdes(Executive Officer)inJohn D. Lister(Executive Officer)in

Co-investorsBlack Diamond Ventures

Agile Stacksagilestacks.comDec 2016

San Mateo, US

Indra Mohan(Director)John Mathon(Executive Officer, Director)

Board seatMaha Ibrahim· per SEC Form D

Co-investorsAlumni VenturesBasecamp FundBlue Ivy VenturesCastor VenturesRosecliff Ventures

Chrono Therapeuticschronothera.comSeries A · Aug 2016 · $32M

HealthtechHayward, US

GUY DIPIERRO(Director)inALAN LEVY, PH.D.(Executive Officer, Director)ANTHONY RIMAC(Executive Officer)ALAN LEVY(Executive Officer, Director)

BoardELIZABETH ROCKETT(Director)

Board seatWende Hutton· per SEC Form D

Co-investorsCota CapitalEmergent Medical Partners, LLPFountain Healthcare PartnersKaiser Permanente VenturesMission Bay Capital5AM Ventures+2 more

Dicom GridinMar 2016

Phoenix, US

MORRIS PANNER(Executive Officer, Director)inMICHAEL PALIN(Chief Financial Officer)inGEOFFREY CRAWSHAW(Executive Officer)

BoardSTEPHEN PAPADOPOULOS(Director)JAMES RAMSEY(Director)

Board seatStephen Bloch· per SEC Form D

World View Enterprisesworldview.spacein𝕏Series B · Feb 2016 · $15M

Worldview provides high-altitude balloon remote sensing and persistent stratospheric observation, integrating sensors and platforms across air, stratosphere, and space into a unified intelligence workflow.

AI & Machine LearningDefense TechSpace TechTravel & HospitalityTucson, US

Taber MacCallum(Founder)inJane Poynter(Founder)inGrant Anderson(Executive Officer, Director)inAlan Stern(Founder)inStephen Wideman(Executive Officer)inRyan Hartman(Executive Officer, Director)in

Board seatDeepak Kamra· per SEC Form D

Co-investorsAccelBase Venture Management, Inc.Breakthrough VictoriaNorwest Venture PartnersRevolutionWestern Technology Investment+2 more

Genome Medical, Inc.gene-matters.comin𝕏Seed · Nov 2016 · $400K

Genome Medical provides telehealth-enabled genetic counseling, testing, and clinical trial access for patients with rare diseases.

BiotechDigital HealthHealthtechMedical Devices

Co-investorsBlue Ivy VenturesiSelect FundIllumina VenturesWalden Catalyst

Iterum Therapeuticsiterumtx.comSeries A · Mar 2016 · $40M

Iterum Therapeutics develops anti-infective compounds to treat infections caused by multi-drug resistant pathogens.

BiotechDigital HealthHealthtechMedical DevicesDublin, US

Michael W. Dunne(Executive Officer, Promoter)inCorey N. Fishman(Executive Officer, Director, Promoter)inJudith M. Matthews(Executive Officer, Promoter)Jeff Schaffnit(Executive Officer)

BoardBrenton K. Ahrens(Director)Ronald M. Hunt(Director)

Co-investorsBay City CapitalSofinnova VenturesAdvent Life SciencesDolby Family VenturesFrazier Life SciencesSofinnova Venture Partners

Leanplumleanplum.comin𝕏Oct 2016 · $29M

Leanplum is a mobile marketing platform (associated with CleverTap) offering engagement and messaging tools for mobile apps.

AI & Machine LearningMarketing TechSaaSSan Francisco, US

Sunil Thomas(Co-founder & CEO)inAndrew First(Founder)Michael Grinich(Founder)Momchil Kyurkchiev(Founder)

Co-investorsEast 11 VenturesKima VenturesLAUNCHub VenturesMultiplier CapitalNorwest Venture PartnersTechstars+3 more

MightyTVinMay 2016Acquired

New York video discovery startup whose Tinder-style app recommended TV and film titles; acquired and shut down by Spotify in 2017.

New York, US

Brian Eugene Adams(Executive Officer, Director)

BoardDan Ciporin(Director)Santo Politi(Director)inMichael Barrett(Director)

Co-investorsSpark Capital

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Annum HealthRevision Optics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.